Insulet Corporation (PODD) Price Target Analysis
Updated Jul 2, 2026
Analyst Rating: Buy
Based on 50 analysts36.7% Below Target
PODD trades 36.7% below Wall Street's consensus target of $220.79.
Current Price$161.55
Average Target$220.79
Target
Current
Low$190.00
Median$217.50
High$280.00
Analyst Target Range
Forward P/E24.9x
(Fair)
PEG Ratio0.24
(Undervalued)
Implied Growth+50.3%
(High Growth)
Analyst Spread40.8%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes PODD achieves its forward estimates and maintains a stable P/E multiple of 24.9x. This scenario reflects the blended consensus of 50 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
PODD Price Target Analysis
Updated July 8, 2026As of July 8, 2026, Insulet Corporation (PODD) has a Wall Street consensus price target of $220.79, based on estimates from 50 covering analysts. With the stock currently trading at $161.55, this represents a potential upside of +36.7%. The company has a market capitalization of $11.34B.
Analyst price targets range from a low of $190.00 to a high of $280.00, representing a 41% spread in expectations. The median target of $217.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 35 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 3 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, PODD trades at a trailing P/E of 46.4x and forward P/E of 24.9x. The forward PEG ratio of 0.24 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +50.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $281.53, with bear and bull scenarios of $177.36 and $370.94 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+28.1%
Industry Consensus
Avg Forward P/E
16.7x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 DXCMDexCom, Inc. | $28.4B | $73.57 | $83.80 | +13.9% | Buy | 28.4x | 52 |
 TNDMTandem Diabetes Care, Inc. | $1.1B | $15.43 | $29.95 | +94.1% | Buy | — | 39 |
 NVCRNovoCure Limited | $2.0B | $17.72 | $33.00 | +86.2% | Buy | — | 15 |
 ITGRInteger Holdings Corporation | $3.2B | $91.90 | $108.00 | +17.5% | Buy | 15.1x | 15 |
 ABTAbbott Laboratories | $166.9B | $95.84 | $125.62 | +31.1% | Buy | 17.5x | 41 |
 MDTMedtronic plc | $107.6B | $83.83 | $95.80 | +14.3% | Buy | 14.1x | 51 |
 BDXBecton, Dickinson and Company | $56.6B | $156.30 | $174.81 | +11.8% | Hold | 12.4x | 34 |
 NVONovo Nordisk A/S | $220.6B | $49.64 | $45.00 | -9.3% | Buy | 2.3x | 39 |
 LLYEli Lilly and Company | $1.2T | $1235.56 | $1269.94 | +2.8% | Buy | 33.7x | 45 |
 SNYSanofi | $103.3B | $42.98 | $51.00 | +18.7% | Hold | 10.2x | 27 |
PODD — Frequently Asked Questions
Quick answers to the most common questions about buying PODD stock.
What is the PODD stock price target for 2026?
The consensus Wall Street price target for PODD is $220.79, representing 36.7% upside from the current price of $161.55. With 50 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is PODD a buy, sell, or hold?
PODD has a consensus rating of "Buy" based on 50 Wall Street analysts. The rating breakdown is predominantly bullish, with 35 Buy/Strong Buy ratings. The consensus 12-month price target of $220.79 implies 36.7% upside from current levels.
Is PODD stock overvalued or undervalued?
PODD trades at a forward P/E of 24.9156x, representing a moderate valuation. With analysts targeting $220.79 (36.7% implied move), the stock appears reasonably valued with upside.
How high can PODD stock go?
The most bullish Wall Street analyst has a price target of $280 for PODD, while the most conservative target is $190. The consensus of $220.79 represents the median expectation. Our quantitative valuation model projects a bull case target of $371 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover PODD stock?
PODD is heavily covered by Wall Street, with 50 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 35 have Buy ratings, 12 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the PODD stock forecast?
The 12-month PODD stock forecast based on 50 Wall Street analysts shows a consensus price target of $220.79, with estimates ranging from $190 (bear case) to $280 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $282, with bear/bull scenarios of $177/$371.
What is PODD's fair value based on fundamentals?
Our quantitative valuation model calculates PODD's fair value at $282 (base case), with a bear case of $177 and bull case of $371. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
What is PODD's forward P/E ratio?
PODD trades at a forward P/E ratio of 24.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 46.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy PODD stock?
Wall Street analysts are very optimistic on PODD, with a "Buy" consensus rating and $220.79 price target (36.7% upside). 35 of 50 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do PODD price targets vary so much?
PODD analyst price targets range from $190 to $280, a 41% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $220.79 consensus represents the middle ground. Our model's $177-$371 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare